US 11168310
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
granted A61KA61K35/12A61K38/45
Quick answer
US patent 11168310 (Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy) held by Entrada Therapeutics, Inc. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Entrada Therapeutics, Inc.
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K35/12, A61K38/45, A61K47/60, A61K47/645